N-(3-(3-cyclopropyl-5-((2-fluoro-4-iodophenyl)amino)-6,8-dimethyl-2,4,7-trioxo-3,4,7,8-tetrahydropyrido[2,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide DMSO solvate
Número de CAS
1187431-43-1
Fórmula Molecular
C28H29FIN5O5S
Peso Molecular
693.53
Pureza
98%
Indicación
Trametinib Intermediate
Descripción del Producto

n May 2013, the US FDA approved trametinib (also referred to as GSK1120212 and JTP-74057), for the treatment of patients with unresectable or metastatic melanoma with BRAFV600e or BRAFV600K mutations as detected by an FDA-approved test